搜索
Search
img

News Center

新闻中心

Kintor: Q3 2021 Business Update at A Glance

Kintor: Q3 2021 Business Update at A Glance

(Summary description)Q3 2021 Business Update at A Glance

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2021-10-10 11:30
  • Views:
Information

Previous: Kintor Pharma Announces China NMPA Approves Clinical Trial of ALK-1 and Nivolumab Combination Therapy for the First-line Treatment of Advanced Hepatocellular Carcinoma
Next: Kintor Pharma Announces First Patient Dosing in Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients in US
Previous: Kintor Pharma Announces China NMPA Approves Clinical Trial of ALK-1 and Nivolumab Combination Therapy for the First-line Treatment of Advanced Hepatocellular Carcinoma
Next: Kintor Pharma Announces First Patient Dosing in Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients in US

Related documents

MORE
There is currently no content to display
Please add data record on website background.

Copyright: Kintor Pharmaceutical Limited retains all copyrights.  苏ICP备19028699号-2  Powered by 300.cn

Complaints and Suggestions Tel: +86 512 62639935 Email: public@kintor.com.cn